VectivBio Holding AG (VECT) Financial Statements
VectivBio Holding AG (VECT) files with the U.S. Securities and Exchange Commission under CIK 0001836379. 10KGenie shows its annual statements from SEC filings.
Key Figures, Fiscal Year 2022
- Revenue
- $27.34 million
- Total Assets
- $252.60 million
- Net Cash from Operations
- -$56.26 million
Fiscal year ended Dec 31, 2022. Latest periodic SEC filing: Apr 19, 2023. Source: SEC filings (EDGAR XBRL).
Open the full financial statements for VECT in 10KGenie
Data from SEC EDGAR filings. 10KGenie is not affiliated with the SEC. SEC Filing History